Le Lézard
Classified in: Health
Subject: TRD

Newtopia to Present at the Bloom Burton & Co. Healthcare Investor Conference


TORONTO, April 19, 2022 /CNW/ - Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled habit change provider focused on preventing, slowing and reversing chronic disease, today announced that Jeff Ruby, Founder and CEO, will participate in the Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto Convention Centre, North Building on May 2nd and 3rd, 2022.

Jeff Ruby, Founder and CEO, will present at 3:00 PM ET on Tuesday, May 3 as well as host investor meetings throughout the two-day conference. The presentation will be webcast live and can be accessed on the Investor Relations' section of Newtopia's website, investor.newtopia.com.

In addition, a copy of the Company's most recent investor presentation is posted in the News & Events section of the Company's investor relations website.

About Newtopia

Newtopia is a tech-enabled habit change provider focused on disease prevention and reducing the cost of care for health insurers. As a provider of whole person care, we prevent, reverse and slow the progression of chronic disease while enriching mental health, resilience and overall human performance. Newtopia's programs leverage genetic, social and behavioral insights to create individualized prevention programs with a focus on type 2 diabetes, heart disease, stroke and weight. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans and is currently listed on the Toronto Stock Exchange (TSXV: NEWU) (OTCQB: NEWUF). To learn more, visit newtopia.com, LinkedIn or Twitter.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Newtopia Inc.


These press releases may also interest you

at 05:45
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders
The Gross Law Firm issues the following notice to shareholders of Anavex Life Sciences Corporation . Shareholders who purchased...

at 05:37
Plastics for Healthcare Packaging Market to Reach $46.1 Billion by 2028: BCC Research
"According to the latest BCC Research study, the demand for Plastics for Healthcare Packaging is growing from $32.1 billion in 2023 to $46.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.5% from 2023 through 2028." This...

at 05:32
/C O R R E C T I O N -- The Adecco Group/
In the news release, AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange, issued 07-May-2024 by The Adecco Group over PR Newswire, we are advised by the client that the headline should read "The Adecco Group: Q1 24 Results"...

at 05:30
NUTEX HEALTH SCHEDULES 2024 FIRST QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
Nutex Health Inc. ("Nutex Health" or the "Company") , a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks,...

at 05:22
Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
"According to the...

at 05:05
Topas Therapeutics Appoints Hugo Fry as CEO
Topas Therapeutics, a clinical-stage biotech company developing novel antigen-specific immune tolerance therapies to treat autoimmune disorders, announced today the appointment of Hugo Fry as its new Chief Executive Officer. Bringing three decades of...

More news about Health...


News published on and distributed by: